Novel Classification for Upper Tract Urothelial Carcinoma to Better Risk-stratify Patients Eligible for Kidney-sparing Strategies: An International Collaborative Study

被引:15
|
作者
Marcq, Gautier [1 ,2 ]
Foerster, Beat [3 ,4 ]
Abufaraj, Mohammad [3 ,5 ]
Matin, Surena F. [6 ]
Azizi, Mounsif [7 ,8 ]
Gupta, Mohit [9 ]
Li, Wei-Ming [10 ,11 ]
Seisen, Thomas [12 ]
Clinton, Timothy [13 ]
Xylinas, Evanguelos [14 ]
Mir, M. Carmen [15 ]
Schweitzer, Donald [16 ]
Mari, Andrea [17 ]
Kimura, Shoji [18 ]
Bandini, Marco [19 ]
Mathieu, Romain [20 ]
Ku, Ja H. [21 ]
Guruli, Georgi [22 ]
Grabbert, Markus [23 ]
Czech, Anna K. [24 ]
Muilwijk, Tim [25 ]
Pycha, Armin [26 ,27 ]
D'Andrea, David [3 ]
Petros, Firas G. [6 ,28 ,29 ]
Spiess, Philippe E. [7 ]
Bivalacqua, Trinity [9 ]
Wu, Wen-Jeng [10 ,11 ]
Roupret, Morgan [12 ]
Krabbe, Laura-Maria [13 ,30 ]
Hendricksen, Kees [16 ]
Egawa, Shin [18 ]
Briganti, Alberto [19 ]
Moschini, Marco [19 ,31 ]
Graffeille, Vivien [18 ]
Autorino, Riccardo [22 ]
John, Patricia [23 ]
Heidenreich, Axel [23 ]
Chlosta, Piotr [24 ]
Joniau, Steven [25 ]
Soria, Francesco [3 ,32 ]
Pierorazio, Phillip M. [9 ]
Shariat, Shahrokh F. [3 ,5 ,13 ,33 ,34 ,35 ,36 ]
Kassouf, Wassim [1 ]
机构
[1] McGill Univ, Hlth Ctr, Div Urol, Dept Surg, Montreal, PQ, Canada
[2] CHU Lille, Claude Huriez Hosp, Urol Dept, Lille, France
[3] Med Univ Vienna, Dept Urol, Vienna, Austria
[4] Kantonsspital Winterthur, Dept Urol, Winterthur, Switzerland
[5] Univ Jordan, Jordan Univ Hosp, Dept Special Surg, Div Urol, Amman, Jordan
[6] MD Anderson Canc Ctr, Dept Urol, Houston, TX USA
[7] H Lee Moffitt Canc Ctr & Res Inst, Dept Genitourinary Oncol, Tampa, FL USA
[8] Univ Montreal, Hop Sacre Coeur Montreal, Div Urol, Dept Surg, Montreal, PQ, Canada
[9] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA
[10] Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan
[11] Kaohsiung Med Univ, Sch Med, Dept Urol, Kaohsiung, Taiwan
[12] Sorbonne Univ, Piti Salpetriere Hosp, AP HP, Predict ONCOURO,Urol,GRC 5, Paris, France
[13] Univ Texas Southwestern Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA
[14] Paris Descartes Univ, Bichat Claude Bernard Hosp, AP HP, Dept Urol, Paris, France
[15] Inst Valenciano Oncol Fdn, Valencia, Spain
[16] Netherlands Canc Inst, Antoni Van Leeuwenhoek Hosp, Dept Urol, Amsterdam, Netherlands
[17] Univ Florence, Careggi Hosp, Dept Urol, Florence, Italy
[18] Jikei Univ, Sch Med, Dept Urol, Tokyo, Japan
[19] Univ Vita Salute San Raffaele, Urol Res Inst, IRCCS Osped San Raffaele, Div Oncol,Unit Urol, Milan, Italy
[20] Univ Rennes, Dept Urol, Rennes, France
[21] Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea
[22] Virginia Commonwealth Univ, Div Urol, Richmond, VA USA
[23] Univ Hosp Cologne, Dept Urol, Urooncol, Cologne, Germany
[24] Jagiellonian Univ Med Coll, Dept Urol, Krakow, Poland
[25] Univ Hosp Leuven, Dept Urol, Leuven, Belgium
[26] Prov Hosp Bozen, Dept Urol, Bolzano, Italy
[27] Sigmund Freud Univ, Med Sch, Vienna, Austria
[28] Univ Toledo, Med Ctr, Dept Urol & Kidney Transplant, 2801 W Bancroft St, Toledo, OH 43606 USA
[29] Eleanor N Dana Canc Ctr, Toledo, OH USA
[30] Univ Hosp Muenster, Dept Urol, Munster, Germany
[31] Luzerner Kantonsspital, Dept Urol, Luzern, Switzerland
[32] Univ Torino, Dept Surg Sci, Sch Med, Div Urol, Turin, Italy
[33] Weill Cornell Med Coll, Dept Urol, New York, NY USA
[34] Karl Landsteiner Inst Urol & Androl, Vienna, Austria
[35] Charles Univ Prague, Fac Med 2, Dept Urol, Prague, Czech Republic
[36] IM Sechenov First Moscow State Med Univ, Inst Urol & Reprod Hlth, Moscow, Russia
来源
EUROPEAN UROLOGY FOCUS | 2022年 / 8卷 / 02期
关键词
Transitional cell carcinoma; Urologic neoplasms; Risk assessment; Urological diagnostic techniques; Urologic surgical procedures; Ureteroscopy; UPPER URINARY-TRACT; BACILLUS-CALMETTE-GUERIN; ENDOSCOPIC MANAGEMENT; BLADDER-CANCER; CELL-CARCINOMA; PREDICTION; GUIDELINES; URETEROSCOPY; EXPERIENCE; OUTCOMES;
D O I
10.1016/j.euf.2021.03.018
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: The European Association of Urology risk stratification dichotomizes patients with upper tract urothelial carcinoma (UTUC) into two risk categories. Objective: To evaluate the predictive value of a new classification to better risk stratify patients eligible for kidney-sparing surgery (KSS). Design, setting, and participants: This was a retrospective study including 1214 patients from 21 centers who underwent ureterorenoscopy (URS) with biopsy followed by radical nephroureterectomy (RNU) for nonmetastatic UTUC between 2000 and 2017. Outcome measurements and statistical analysis: A multivariate logistic regression analysis identified predictors of muscle invasion (>= pT2) at RNU. The Youden index was used to identify cutoff points. Results and limitations: A total of 811 patients (67%) were male and the median age was 71 yr (interquartile range 63-77). The presence of non-organ-confined disease on preoperative imaging (p < 0.0001), sessile tumor (p < 0.0001), hydronephrosis (p 0.0003), high-grade cytology (p - 0.0043), or biopsy (p - 0.0174) and higher age at diagnosis (p = 0.029) were independently associated with >= pT2 at RNU. Tumor size was significantly associated with >= pT2 disease only in univariate analysis with a cutoff of 2 cm. Tumor size and all significant categorical variables defined the high-risk category. Tumor multifocality and a history of radical cystectomy help to dichotomize between low-risk and intermediate-risk categories. The odds ratio for muscle invasion were 5.5 (95% confidence interval [CI) 1.3-24.0; p = 0.023) for intermediate risk versus low risk, and 12.7 (95% CI 3.0-54.5; p = 0.0006) for high risk versus low risk. Limitations include the retrospective design and selection bias (all patients underwent RNU). Conclusions: Patients with low-risk UTUC represent ideal candidates for KSS, while some patients with intermediate-risk UTUC may also be considered. This classification needs further prospective validation and may help stratification in clinical trial design. Patient summary: We investigated factors predicting stage 2 or greater cancer of the upper urinary tract at the time of surgery for ureter and kidney removal and designed a new risk stratification. Patients with low or intermediate risk may be eligible for kidney-sparing surgery with close follow-up. Our classification scheme needs further validation based on cancer outcomes. (C) 2021 European Association of Urology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:491 / 497
页数:7
相关论文
共 50 条
  • [1] Re: Novel Classification for Upper Tract Urothelial Carcinoma to Better Risk-stratify Patients Eligible for Kidney-sparing Strategies: An International Collaborative Study
    Lonati, Chiara
    Suardi, Nazareno
    [J]. EUROPEAN UROLOGY, 2022, 82 (05) : 574 - 574
  • [2] Novel classification for upper tract urothelial carcinoma to better risk-stratify patients eligible for kidney sparing strategies: an international collaborative study
    Marcq, G.
    Foerster, B.
    Matin, S. F.
    Spiess, P.
    Bivalacqua, T.
    Wu, W.
    Roupret, M.
    Krabbe, L. M.
    Xylinas, E.
    Mir, C.
    Hendricksen, K.
    Mari, A.
    Egawa, S.
    Briganti, A.
    Moschini, M.
    Mathieu, R.
    Ku, J. H.
    Autorino, R.
    Heidenreich, A.
    Chlosta, P.
    Joniau, S.
    Pycha, A.
    D'andrea, D.
    Shariat, S. F.
    Kassouf, W.
    Wu, Wen-Jeng
    [J]. EUROPEAN UROLOGY, 2021, 79 : S1085 - S1086
  • [3] Pretreatment Risk Stratification for Endoscopic Kidney-sparing Surgery in Upper Tract Urothelial Carcinoma: An International Collaborative Study
    Foerster, Beat
    Abufaraj, Mohammad
    Matin, Surena F.
    Azizi, Mounsif
    Gupta, Mohit
    Li, Wei-Ming
    Seisen, Thomas
    Clinton, Timothy
    Xylinas, Evanguelos
    Mir, M. Carmen
    Schweitzer, Donald
    Mari, Andrea
    Kimura, Shoji
    Bandini, Marco
    Mathieu, Romain
    Ku, Ja H.
    Marcq, Gautier
    Guruli, Georgi
    Grabbert, Markus
    Czech, Anna K.
    Muilwijk, Tim
    Pycha, Armin
    D'Andrea, David
    Petros, Firas G.
    Spiess, Philippe E.
    Bivalacqua, Trinity
    Wu, Wen-Jeng
    Roupret, Morgan
    Krabbe, Laura-Maria
    Hendricksen, Kees
    Egawa, Shin
    Briganti, Alberto
    Moschini, Marco
    Graffeille, Vivien
    Kassouf, Wassim
    Autorino, Riccardo
    Heidenreich, Axel
    Chlosta, Piotr
    Joniau, Steven
    Soria, Francesco
    Pierorazio, Phillip M.
    Shariat, Shahrokh F.
    [J]. EUROPEAN UROLOGY, 2021, 80 (04) : 507 - 515
  • [4] Re: Pretreatment Risk Stratification for Endoscopic Kidney-sparing Surgery in Upper Tract Urothelial Carcinoma: An International Collaborative Study
    Gallioli, Andrea
    Breda, Alberto
    Palou, Joan
    [J]. EUROPEAN UROLOGY, 2022, 81 (04) : 428 - 429
  • [5] Modern Kidney-Sparing Management of Upper Tract Urothelial Carcinoma
    Ghoreifi, Alireza
    Sari Motlagh, Reza
    Fuchs, Gerhard
    [J]. CANCERS, 2023, 15 (18)
  • [6] NEW CLASSIFICATION FOR UPPER TRACT UROTHELIAL CARCINOMA TO ENHANCE RISK STRATIFICATION OF PATIENTS ELIGIBLE TO ENDOSCOPIC MANAGEMENT: AN INTERNATIONAL COLLABORATIVE STUDY
    Marcq, Gautier
    Foerster, Beat
    Matin, Surena F.
    Azizi, Mounsif
    Gupta, Mohit
    Li, Wei-Ming
    Seisen, Thomas
    Clinton, Timothy
    Xylinas, Evanguelos
    Carmen, Mir
    Rubio-Briones, Jose
    Schweitzer, Donald
    Mari, Andrea
    Kimura, Shoji
    Bandini, Marco
    Mathieu, Romain
    Ku, Ja H.
    Anele, Uzoma
    Grabbert, Markus
    Czech, Anna K.
    Muilwijk, Tim
    Pycha, Armin
    Abufaraj, Mohammad
    D'Andrea, David
    Petros, Firas
    Spiess, Philippe E.
    Bivalacqua, Trinity
    Wu, Wen-Jengz
    Roupret, Morgan
    Krabbe, Laura-Maria
    Hendricksen, Kees
    Egawa, Shin
    Briganti, Alberto
    Moschini, Marco
    Autorino, Riccardo
    Heidenreich, Axel
    Chlosta, Piotr
    Joniau, Steven
    Soria, Francesco
    Pierorazio, Phillip
    Shariat, Shahrokh F.
    Kassouf, Wassim
    [J]. JOURNAL OF UROLOGY, 2020, 203 : E1247 - E1248
  • [7] Diagnosis and kidney-sparing treatments for upper tract urothelial carcinoma: state of the art
    Territo, Angelo
    Foerster, Bear
    Shariat, Shahrokh F.
    Roupret, Morgan
    Gaya, Jose M.
    Palou, Joan
    Breda, Alberto
    [J]. MINERVA UROLOGICA E NEFROLOGICA, 2018, 70 (03) : 242 - +
  • [8] Intracavitary Chemotherapy after kidney-Sparing Therapy for Upper Tract Urothelial Carcinoma: A Meta-Analysis
    Zhou, Hang
    Pan, Yang
    Xu, Mingming
    Wang, Shangren
    Li, Yuezheng
    Liu, Xiaoqiang
    [J]. UROLOGY JOURNAL, 2023, 20 (06) : 369 - 378
  • [9] Risk stratification for kidney sparing procedure in upper tract urothelial carcinoma
    Khene, Zine-Eddine
    Mathieu, Romain
    Kammerer-Jacquet, Solene-Florence
    Seisen, Thomas
    Roupret, Morgan
    Shariat, Shahrokh F.
    Peyronnet, Benoit
    Bensalah, Karim
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2016, 5 (05) : 711 - 719
  • [10] Overcoming Understaging and Undergrading in Upper Tract Urothelial Carcinoma. Comment on Ghoreifi et al. Modern Kidney-Sparing Management of Upper Tract Urothelial Carcinoma
    Jue, Joshua S.
    Alameddine, Mahmoud
    Armenakas, Noel A.
    [J]. CANCERS, 2024, 16 (05)